These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Agonist of the adenosine A3 receptor, IB-MECA, and inhibitor of cyclooxygenase-2, meloxicam, given alone or in a combination early after total body irradiation enhance survival of γ-irradiated mice. Hofer M, Pospíšil M, Dušek L, Hoferová Z, Komůrková D. Radiat Environ Biophys; 2014 Mar; 53(1):211-5. PubMed ID: 24263216 [Abstract] [Full Text] [Related]
4. Inhibition of cyclooxygenase 2 in mice increases production of g-csf and induces radioprotection. Hofer M, Pospísil M, Holá J, Vacek A, Streitová D, Znojil V. Radiat Res; 2008 Nov; 170(5):566-71. PubMed ID: 18959461 [Abstract] [Full Text] [Related]
11. Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration. Kuipers GK, Slotman BJ, Wedekind LE, Stoter TR, Berg Jv, Sminia P, Lafleur MV. Int J Radiat Biol; 2007 Oct; 83(10):677-85. PubMed ID: 17729162 [Abstract] [Full Text] [Related]
12. Radiosensitizing potential of the selective cyclooygenase-2 (COX-2) inhibitor meloxicam on human glioma cells. Bijnsdorp IV, van den Berg J, Kuipers GK, Wedekind LE, Slotman BJ, van Rijn J, Lafleur MV, Sminia P. J Neurooncol; 2007 Oct; 85(1):25-31. PubMed ID: 17447009 [Abstract] [Full Text] [Related]